STOCK TITAN

Lisata Therapeutics (LSTA) Revenue by Year

LSTA NASDAQ

Lisata Therapeutics, Inc. generated $170K in revenue in fiscal year 2025. This represents a decrease of 83.0% from the prior fiscal year. Over the trailing 12 months, Q4 FY2025 through Q3 FY2026, the same line adds up to $100K in revenue. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Lisata Therapeutics, Inc. has filed alongside them.

FY2025 annual
Revenue $170K
YoY -83.0%
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Sep 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

LSTA Revenue by Fiscal Year

Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
Revenue$100K$170K-83.0%$1.0Mn/m$0n/m$0N/AN/AN/AN/AN/A$35.3M+56.9%$22.5M+25.4%$17.9M+22.3%$14.7M+2.4%$14.3M+42.6%$10.1M

TTM is the trailing twelve months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings.

LSTA Revenue by Quarter

Figures are in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-K
Revenue$0n/m$0-100.0%$0n/m$100K-90.0%$0n/m$70Kn/m$0n/m$1.0Mn/m$0n/m$0n/m$0n/m$0

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Lisata Therapeutics, Inc. financials

Frequently Asked Questions

Lisata Therapeutics, Inc. generated $170K in revenue in fiscal year 2025.

Lisata Therapeutics, Inc. (LSTA) revenue fell by 83.0% year over year, from $1.0M to $170K in fiscal year 2025.

Lisata Therapeutics, Inc. (LSTA) reported $100K in revenue over the trailing 12 months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings.

Across the 15 fiscal years this page covers, Lisata Therapeutics, Inc. (LSTA) revenue went from $10.1M in fiscal year 2011 to $170K in fiscal year 2025.

Lisata Therapeutics, Inc. (LSTA) reported $0 in revenue in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Lisata Therapeutics, Inc. (LSTA) reported on that line in every period on record.